fp7 logo
fp7 logo
nabativi bacteria
logo NABATIVI
Novel Approaches to Bacterial Target Identification
Validation and Inhibition
NABATIVI is a network with a strategic objective in the area of antimicrobial drug resistance and infectious diseases research. Nine leading European research teams combine their expertise and resources in a multi-disciplinary approach through the development of novel antibacterial against the gram-negative Pseudomonas aeruginosa and Burkholderia cenocepacia. Focus is on combining basic research on molecular mechanisms of resistance, and host-pathogen interactions with clinical resources towards identification and validation of novel drugs target. Close interaction with SMEs will ensure that suitable targets can rapidly be transferred into drug development.
NABATIVI is a network with a strategic objective in the area of antimicrobial drug resistance and infectious diseases research. Nine leading European research teams combine their expertise and resources in a multi-disciplinary approach through the development of novel antibacterial against the gram-negative Pseudomonas aeruginosa and Burkholderia cenocepacia. Focus is on combining basic research on molecular mechanisms of resistance, and host-pathogen interactions with clinical resources towards identification and validation of novel drugs target. Close interaction with SMEs will ensure that suitable targets can rapidly be transferred into drug development.